SCHEDULE 13D

Company

ABVC BIOPHARMA, INC.

Filed

July 12, 2022

Accession Number

0001213900-22-038902

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →